Solana Co 8-K Filing
Ticker: HSDT · Form: 8-K · Filed: Oct 31, 2025 · CIK: 1610853
| Field | Detail |
|---|---|
| Company | Solana Co (HSDT) |
| Form Type | 8-K |
| Filed Date | Oct 31, 2025 |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Solana Co (ticker: HSDT) to the SEC on Oct 31, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (hich registered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar).
How long is this filing?
Solana Co's 8-K filing is 3 pages with approximately 834 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 834 words · 3 min read · ~3 pages · Grade level 17.8 · Accepted 2025-10-31 09:24:50
Key Financial Figures
- $0.001 — hich registered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar
Filing Documents
- hsdt-20251030x8k.htm (8-K) — 64KB
- hsdt-20251030x8k001.jpg (GRAPHIC) — 6KB
- 0001104659-25-104700.txt ( ) — 192KB
- hsdt-20251030.xsd (EX-101.SCH) — 3KB
- hsdt-20251030_lab.xml (EX-101.LAB) — 16KB
- hsdt-20251030_pre.xml (EX-101.PRE) — 10KB
- hsdt-20251030x8k_htm.xml (XML) — 5KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. At the special meeting of stockholders of Solana Company (formerly known as Helius Medical Technologies, Inc.) (the "Company") held on October 30, 2025 (the "Special Meeting"), the Company's stockholders: (i) elected one new director to the Company's Board of Directors; (ii) approved, in accordance with Nasdaq Listing Rule 5635(a), the issuance of shares of the Company's Class A common stock, par value $0.001 per share (the "Common Stock") upon the exercise of the Strategic Advisor Warrants issued to Pantera Capital Management LP and Summer Wisdom Holdings Limited; (iii) approved, in accordance with Nasdaq Listing Rule 5635(a), the issuance of shares of the Common Stock upon the exercise of the Cryptocurrency Pre-Funded Warrants and Cryptocurrency Stapled Warrants issued in connection with our acceptance of Solana (SOL) cryptocurrency as consideration in our private placement offering; (iv) approved an amendment to the Helius Medical Technologies, Inc. 2022 Equity Incentive Plan to increase the number of shares of Common Stock available for issuance thereunder by 4,000,000 shares; and (v) approved the authorization of one or more adjournments to the Special Meeting to solicit additional proxies in the event there were insufficient votes to approve the foregoing proposals. The numbers reported below are based on 40,299,220 shares of Common Stock outstanding and entitled to vote as of September 26, 2025, the record date of the Special Meeting, and 21,742,341 shares of Common Stock were represented in person or by proxy at the Special Meeting, which number constituted a quorum. Proposal 1 : Election of the sole nominee, Cosmo Jiang, to the Company's Board of Directors: Votes For Votes Withheld Broker Non-Votes 21,737,666 4,675 0 Proposal 2: Approval of, in accordance with Nasdaq Listing Rule 5635(a), the issuance of shares of the Company's Common Stock upon the exercise of the Strategic Advisor